Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Learn which credit cards offer the best rewards points and make informed choices to maximize your benefits. Start comparing today!
28,095 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
When a major momentum bet is unwound, it sends signals about risk tolerance and market breadth. This article explains...
Regulators revived a stalled pipeline, prompting questions for investors in Sable Offshore. This guide breaks down wh...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
SpaceX could be the market's most talked-about IPO. This guide breaks down what to know, how to evaluate the opportun...
With the Social Security trust fund projected to run dry by the early 2030s, Congress faces a high-stakes fight over ...
As a new Fed leadership team takes the reins, investors are bracing for a steadier communications stance. Analysts sa...
A top executive at Urban Outfitters sold a sizable block of stock in a short time frame. This article breaks down wha...
Walmart is more than a giant retailer. This analysis explains whether its size translates into a durable moat and wha...
Minnesota’s business elite issued a restrained message on immigration enforcement that drew sharp critique and raised...
As brokerages race to attract new investors, free stock promotions are surging in March 2026. This report explains ho...
Many workers find themselves taking on tasks they didn’t apply for, often with no raise or promotion in sight. This a...